lly glp 1 drug Stock Surges on Breakthrough Oral GLP-1 Trial Results The Rise of GLP-1 Medications

In rare cases, more severe side effects such as pancreatitis may occur

In many cases, the biggest challenges come from small habits that gradually make consistency harder to maintain

doi:10.2337/diabetes.50.8.1720 235

M.BushongE

4 N = 25 had repeat CRP levelsno significant changes (median 3 mg/L for initial & repeat), N = 3 had repeat faecal calprotectin (not enough for statistical analysis), one repeat FCP was 2080 mcg/g, prompting steroid commencement (5 months after initiating semaglutide), and N = 6 had a change in IBD therapy after starting GLP-1 RA (N = 4 had signs of inflammation prior starting GLP-1 RA)

Cardiovascular disease and risk management: standards of care in diabetes2023